4//SEC Filing
MORNEAU MICHAEL 4
Accession 0001209191-20-001428
CIK 0001607678other
Filed
Jan 2, 7:00 PM ET
Accepted
Jan 3, 8:03 PM ET
Size
5.4 KB
Accession
0001209191-20-001428
Insider Transaction Report
Form 4
MORNEAU MICHAEL
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2020-01-03+40,000→ 40,000 totalExercise: $7.77From: 2021-01-03Exp: 2030-01-03→ Common Stock (40,000 underlying)
Footnotes (1)
- [F1]25% of the shares subject to the option will vest on each anniversary of the grant date.
Documents
Issuer
Viking Therapeutics, Inc.
CIK 0001607678
Entity typeother
Related Parties
1- filerCIK 0001517780
Filing Metadata
- Form type
- 4
- Filed
- Jan 2, 7:00 PM ET
- Accepted
- Jan 3, 8:03 PM ET
- Size
- 5.4 KB